Aethlon Medical (AEMD) Cash from Investing Activities (2010 - 2026)
Aethlon Medical (AEMD) posted Cash from Investing Activities of -$2051.0 for Q1 2026, down 193.57% on a QoQ basis from $2192.0 in Q1 2025, and down 193.57% year-over-year from $2192.0 in Q1 2025.
Aethlon Medical (AEMD) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Aethlon Medical's Cash from Investing Activities history runs 16 years deep, the most recent figure standing at -$2051.0 for Q1 2026.
- Quarterly Cash from Investing Activities fell 193.57% year-over-year to -$2051.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2051.0 (changed N/A YoY) and the FY2026 annual result came in at -$3704.0, changed N/A from the prior year.
- Cash from Investing Activities was -$2051.0 for Q1 2026 at Aethlon Medical, down from $2192.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $2192.0 in Q1 2025 and bottomed at -$739165.0 in Q3 2022.
- A 5-year average of -$117368.8 and a median of -$10048.0 in 2023 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities sank 3944.91% — and 2025, when it soared 144.67%.
- Aethlon Medical's Cash from Investing Activities stood at -$151486.0 in 2022, then jumped by 94.19% to -$8807.0 in 2023, then soared by 75.11% to -$2192.0 in 2024, then jumped by 200.0% to $2192.0 in 2025, then sank by 193.57% to -$2051.0 in 2026.
- Business Quant data shows AEMD's Cash from Investing Activities at -$2051.0 in Q1 2026, $2192.0 in Q1 2025, and -$2192.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -298.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -475.32 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Aethlon Medical | 7,224.60 | 7,224.60 | - | -2,051.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,051.00 |
| Mar 31, 2026 | -2,051.00 |
| Mar 31, 2025 | 2,192.00 |
| Mar 31, 2025 | 2,192.00 |
| Dec 31, 2024 | -2,192.00 |
| Dec 31, 2024 | -2,192.00 |
| Mar 31, 2024 | -4,907.00 |
| Mar 31, 2024 | -4,907.00 |
| Dec 31, 2023 | -8,807.00 |
| Dec 31, 2023 | -8,807.00 |
| Sep 30, 2023 | -6,770.00 |
| Sep 30, 2023 | -6,770.00 |
| Jun 30, 2023 | -230,383.00 |
| Jun 30, 2023 | -230,383.00 |
| Mar 31, 2023 | -11,289.00 |
| Mar 31, 2023 | -11,289.00 |
| Dec 31, 2022 | -151,486.00 |
| Dec 31, 2022 | -151,486.00 |
| Sep 30, 2022 | -739,165.00 |
| Sep 30, 2022 | -739,165.00 |